in Cardiolog… · BIOSOLVE-II 150 pm Magnesium Sirolimus Tantalum markers 0.27±0.37 (6-m) Up to...

1

Transcript of in Cardiolog… · BIOSOLVE-II 150 pm Magnesium Sirolimus Tantalum markers 0.27±0.37 (6-m) Up to...

Page 1: in Cardiolog… · BIOSOLVE-II 150 pm Magnesium Sirolimus Tantalum markers 0.27±0.37 (6-m) Up to I-Y Regulatory approval: EU CE mark / US FDA 6-m: 1.7% MACE Vascular Scaffold/ Abbott

Biosolve E - freshbydesign.com.au

Biosolve E - freshbydesign.com.au

Effectiveness of Complete Lesion Coverage with Sirolimus ...Effectiveness of Complete Lesion Coverage with Sirolimus-Eluting Stent for Ostial Left Anterior Descending Artery Stenosis

Effectiveness of Complete Lesion Coverage with Sirolimus ...Effectiveness of Complete Lesion Coverage with Sirolimus-Eluting Stent for Ostial Left Anterior Descending Artery Stenosis

Sirolimus and Metformin Synergistically Inhibits Colon ...€¦ · Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo We estimated the effect of various

Sirolimus and Metformin Synergistically Inhibits Colon ...€¦ · Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo We estimated the effect of various

Sirolimus-eluting Stents: Present and Future

Sirolimus-eluting Stents: Present and Future

sirolimus in hyperinsulnisim Journal club

sirolimus in hyperinsulnisim Journal club

Vascular Intervention // Coronary Resorbable Magnesium Scaffold …€¦ · BIOSOLVE-IV4 (n=198) 4.6% TLF* 12 months BIOSOLVE-II/III5, 6 (n=180) 3.3% TLF* 36 months BIOSOLVE-II7 (n=117)

Vascular Intervention // Coronary Resorbable Magnesium Scaffold …€¦ · BIOSOLVE-IV4 (n=198) 4.6% TLF* 12 months BIOSOLVE-II/III5, 6 (n=180) 3.3% TLF* 36 months BIOSOLVE-II7 (n=117)

Verruca Eradication Following Conversion to Sirolimus in a ...

Verruca Eradication Following Conversion to Sirolimus in a ...

CardioLog Analytics On-Prem Release Notes

CardioLog Analytics On-Prem Release Notes

Sirolimus Therapy in Congenital Hyperinsulinism: A ... · Sirolimus Therapy in Congenital Hyperinsulinism: A Successful Experience Beyond Infancy Marta Minute, MD a, Giuseppa Patti,

Sirolimus Therapy in Congenital Hyperinsulinism: A ... · Sirolimus Therapy in Congenital Hyperinsulinism: A Successful Experience Beyond Infancy Marta Minute, MD a, Giuseppa Patti,

MONDAY, SEPTEMBER 24, 2018 - CRF · BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude _PM Roundtable Discussion With Audience QA 2:45 _PM TCT 64: Two Year Clinical and Imaging

MONDAY, SEPTEMBER 24, 2018 - CRF · BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude _PM Roundtable Discussion With Audience QA 2:45 _PM TCT 64: Two Year Clinical and Imaging

Biosolve Digital Brochure - Home | The BioSolve® Company

Biosolve Digital Brochure - Home | The BioSolve® Company

Sirolimus - Findacure · Sirolimus –a lifeline Dr Hussain and HI team suggested Scarlett start sirolimus on the basis that there is no harm trying at this stage. Scarlett fed well

Sirolimus - Findacure · Sirolimus –a lifeline Dr Hussain and HI team suggested Scarlett start sirolimus on the basis that there is no harm trying at this stage. Scarlett fed well

nab-Sirolimus for Patients With Malignant Perivascular ...

nab-Sirolimus for Patients With Malignant Perivascular ...

Long-term Clinical Outcomes of a Unique Sirolimus-eluting ... · Crystalline Sirolimus with a Rapidly Absorbed Polymer Coating MiStent Crystalline Sirolimus • Unique to MiStent

Long-term Clinical Outcomes of a Unique Sirolimus-eluting ... · Crystalline Sirolimus with a Rapidly Absorbed Polymer Coating MiStent Crystalline Sirolimus • Unique to MiStent

Cardiolog Analytics for Sharepoint Intranet Portals - from Intlock and Atidan

Cardiolog Analytics for Sharepoint Intranet Portals - from Intlock and Atidan

Biosolve digital brochure 2014 pb

Biosolve digital brochure 2014 pb

Long-term clinical data of the BIOSOLVE-II study with the ...

Long-term clinical data of the BIOSOLVE-II study with the ...

Multicenter International LAM Efficacy of Sirolimus (MILES) Trial

Multicenter International LAM Efficacy of Sirolimus (MILES) Trial

CardioLog 2011 Administrator Guide · 2016. 10. 6. · SharePoint version. Click Next. CardioLog Configuration Wizard 3. In the Usage Tracking dialog, enter the SharePoint WFE name

CardioLog 2011 Administrator Guide · 2016. 10. 6. · SharePoint version. Click Next. CardioLog Configuration Wizard 3. In the Usage Tracking dialog, enter the SharePoint WFE name

Prospective, Randomized Evaluation of Sirolimus-Eluting ...

Prospective, Randomized Evaluation of Sirolimus-Eluting ...